精密栄養の市場は、予測期間中に16.2%のCAGRで、2029年までに128億9000万ドルに達すると予測されます。このレポートでは、Viome Life Sciences, Inc.(米国)、Prenetics Global Limited(中国)、ZOE Limited(英国)、myDNA Life Australia Pty Ltd.(オーストラリア)、23andMe, Inc.(米国)、DayTwo Inc.(米国)、Nutrigenomix(カナダ)、ジェネシスヘルスケア(日本)、AMILI(シンガポール)、SelfDecode(米国)などの主要企業を紹介しています。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS AND EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 UNIT CONSIDERED
1.5.1 CURRENCY/VALUE UNIT
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.2.2.1 Approach to estimate market size using top-down analysis
2.3 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PRECISION NUTRITION MARKET
4.2 NORTH AMERICA: PRECISION NUTRITION MARKET, BY APPLICATION AND COUNTRY
4.3 PRECISION NUTRITION MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS
4.4 PRECISION NUTRITION MARKET, BY TECHNOLOGY AND REGION
4.5 PRECISION NUTRITION MARKET, BY SERVICE TYPE AND REGION
4.6 PRECISION NUTRITION MARKET, BY SUPPLEMENT AND REGION
4.7 PRECISION NUTRITION MARKET, BY APPLICATION AND REGION
4.8 PRECISION NUTRITION MARKET, BY END USE AND REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 INCREASE IN HEALTHCARE EXPENDITURES
5.2.2 INCREASE IN GLOBAL GDP
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Growing awareness of personalized health
5.3.1.2 Boom in global wellness economy
5.3.1.3 Rise in non-communicable diseases
5.3.2 RESTRAINTS
5.3.2.1 High cost of precision nutrition solutions
5.3.2.2 Lack of standardization and comprehensive scientific validation
5.3.3 OPPORTUNITIES
5.3.3.1 Integration of AI and big data analytics
5.3.3.2 Rising adoption of digital health tools
5.3.4 CHALLENGES
5.3.4.1 Privacy and data security concerns
5.3.4.2 Addressing consumer skepticism
5.4 IMPACT OF AI/GEN AI ON PRECISION NUTRITION MARKET
5.4.1 INTRODUCTION
5.4.2 USE OF GEN AI IN PRECISION NUTRITION
5.4.3 CASE STUDY ANALYSIS
5.4.3.1 Transforming personalized nutrition with Nutrigenomix
5.4.3.2 IBM Watson and PathAI's impact on specialized healthcare
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
6.2.1 DATA COLLECTION
6.2.2 DATA ANALYSIS AND RECOMMENDATION
6.2.3 CUSTOMIZED NUTRITION SOLUTIONS
6.2.4 PRODUCT DELIVERY
6.3 TRADE ANALYSIS
6.3.1 EXPORT SCENARIO OF HS CODE 3822
6.3.2 IMPORT SCENARIO OF HS CODE 3822
6.4 TECHNOLOGY ANALYSIS
6.4.1 KEY TECHNOLOGIES
6.4.1.1 Artificial intelligence and machine learning
6.4.2 COMPLEMENTARY TECHNOLOGIES
6.4.2.1 Advanced imaging and biosensors
6.4.3 ADJACENT TECHNOLOGIES
6.4.3.1 Virtual health platforms and telemedicine
6.5 PRICING ANALYSIS
6.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY GENOMICS AND MULTI-OMICS ANALYSIS SERVICES
6.6 ECOSYSTEM ANALYSIS
6.6.1 DEMAND-SIDE
6.6.2 SUPPLY-SIDE
6.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
6.8 PATENT ANALYSIS
6.9 KEY CONFERENCES AND EVENTS, 2024-2025
6.10 REGULATORY LANDSCAPE
6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.10.2 NORTH AMERICA
6.10.2.1 US
6.10.2.2 Canada
6.10.2.3 Mexico
6.10.3 EUROPE
6.10.3.1 European Union Regulations
6.10.3.1.1 Processing of personal data
6.10.3.1.2 Borderline products
6.10.3.1.3 Nutrition & health claims
6.10.4 ASIA PACIFIC
6.10.4.1 China
6.10.4.2 India
6.10.4.3 Australia & New Zealand
6.10.5 SOUTH AMERICA
6.10.5.1 Brazil
6.10.5.2 Argentina
6.11 PORTER'S FIVE FORCES ANALYSIS
6.11.1 INTENSITY OF COMPETITIVE RIVALRY
6.11.2 BARGAINING POWER OF SUPPLIERS
6.11.3 BARGAINING POWER OF BUYERS
6.11.4 THREAT OF SUBSTITUTES
6.11.5 THREAT OF NEW ENTRANTS
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
6.12.2 BUYING CRITERIA
6.13 CASE STUDY ANALYSIS
6.13.1 LAUNCH OF 23ANDME+ TOTAL HEALTH MEMBERSHIP
6.13.2 GENESIS HEALTHCARE CO. EXPANDS WHOLE GENOME SEQUENCING CAPABILITIES
6.13.3 VIOME LIFE SCIENCES LAUNCHES FULL BODY INTELLIGENCE TEST
6.14 INVESTMENT AND FUNDING SCENARIO
7 PRECISION NUTRITION MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
7.2 METABOLOMICS
7.2.1 RISING NEED FOR METABOLIC HEALTH SOLUTIONS IN CHRONIC DISEASE CONTROL TO DRIVE MARKET
7.3 GENOMICS
7.3.1 FALLING GENETIC TESTING COSTS AND RISING PUBLIC INTEREST IN NUTRIGENOMICS TO DRIVE DEMAND
7.4 TRANSCRIPTOMICS
7.4.1 SEQUENCING ADVANCES PROPEL RNA RESEARCH AND BOOST TRANSCRIPTOMICS IN PRECISION NUTRITION
7.5 PROTEOMICS
7.5.1 ADVANCEMENTS IN MASS SPECTROMETRY AND BIOINFORMATICS TO FUEL DEMAND
7.6 OTHER TECHNOLOGIES
8 PRECISION NUTRITION MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 WEIGHT MANAGEMENT
8.2.1 RISING RATES OF OVERWEIGHT AND OBESITY TO DRIVE MARKET
8.3 DISEASE MANAGEMENT
8.3.1 SURGE IN CHRONIC DISEASE RATES AND BREAKTHROUGHS IN GENOMICS AND BIOTECH TO DRIVE MARKET
8.4 SPORTS NUTRITION
8.4.1 GROWING FOCUS ON PERSONALIZED HEALTH ASSESSMENTS AND ADJUSTMENTS TO DRIVE DEMAND
8.5 GENERAL HEALTH & WELLNESS
8.5.1 GROWING EMPHASIS ON PERSONALIZED DIETARY GUIDANCE FOR LONG-TERM HEALTH TO DRIVE DEMAND
9 PRECISION NUTRITION MARKET, BY SERVICE TYPE
9.1 INTRODUCTION
9.2 GENOMICS & MULTI-OMICS ANALYSIS SERVICES
9.2.1 INCREASING DEMAND FOR GENOMIC-BASED DIETARY SERVICES TO DRIVE MARKET
9.3 PERSONALIZED PLANS & SUBSCRIPTION SERVICES
9.3.1 NEED FOR CONVENIENCE AND CUSTOMIZED WELLNESS PROGRAMS TO DRIVE DEMAND
9.4 CONSULTATION SERVICES
9.4.1 INCREASING DEMAND FOR EXPERT GUIDANCE ON SPECIFIC HEALTH CONDITIONS TO DRIVE MARKET
9.5 DIGITAL PLATFORMS & SOLUTIONS
9.5.1 INNOVATIONS IN AI TECHNOLOGY AND WIDESPREAD ADOPTION OF WEARABLE DEVICES TO DRIVE MARKET
9.6 INSTITUTIONAL & WELLNESS PROGRAMS
9.6.1 SURGE IN HEALTHCARE EXPENDITURES AND DEMAND FOR CREDIBLE, EVIDENCE-BASED WELLNESS PROGRAMS TO DRIVE MARKET
10 PRECISION NUTRITION MARKET, BY END USE
10.1 INTRODUCTION
10.2 HEALTHCARE PROVIDERS
10.2.1 HEALTHCARE PROVIDERS PLAY SIGNIFICANT ROLE IN ADVANCING PRECISION MEDICINE
10.3 RESEARCH INSTITUTES
10.3.1 DEMAND FOR SAFE, EFFECTIVE, AND EVIDENCE-BASED PERSONALIZED NUTRITION SOLUTIONS TO DRIVE MARKET
10.4 DIETARY SUPPLEMENT MANUFACTURERS
10.4.1 PRECISION NUTRITION TREND WITH TRANSPARENT, EVIDENCE-BACKED FORMULATIONS TO BOOST MARKET
10.5 FITNESS & WELLNESS COMPANIES
10.5.1 GROWING PREFERENCE FOR HIGH-LEVEL PERSONALIZATION IN FITNESS AND NUTRITION TO DRIVE MARKET
10.6 DIRECT-TO-CONSUMERS
10.6.1 RISING POPULARITY OF GENETIC TESTING KITS, HOME HEALTH ASSESSMENTS, AND NUTRITION-TRACKING APPS TO DRIVE MARKET
11 PRECISION NUTRITION MARKET, BY SUPPLEMENT
11.1 INTRODUCTION
11.2 VITAMINS
11.2.1 RISING AGING POPULATION TO DRIVE DEMAND
11.3 MINERALS
11.3.1 RISING CASES OF OSTEOPOROSIS AND IRON DEFICIENCY TO DRIVE MARKET
11.4 PROBIOTICS
11.4.1 INCREASING POPULARITY OF DIGESTIVE HEALTH SUPPLEMENTS TO INCREASE DEMAND
11.5 HERBAL SUPPLEMENTS
11.5.1 INCREASING FOCUS ON PERSONALIZED HERBAL SOLUTIONS FOR GENERAL HEALTH & WELLNESS TO EXPAND MARKET
11.6 PROTEIN SUPPLEMENTS
11.6.1 RISING DEMAND FOR PLANT-BASED DIETS TO DRIVE DEMAND
11.7 AMINO ACIDS
11.7.1 GROWING USE IN SPORTS NUTRITION TO INCREASE DEMAND
11.8 ENZYMES
11.8.1 NUTRIENT ABSORPTION BENEFITS TO DRIVE DEMAND
11.9 OTHER SUPPLEMENTS
12 PRECISION NUTRITION MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 US
12.2.1.1 Advancements in AI, availability of rich datasets, and growing public interest in personalized nutrition to drive market
12.2.2 CANADA
12.2.2.1 Supportive healthcare policies and growing focus on long-term health to drive market
12.2.3 MEXICO
12.2.3.1 Increasing public health concerns, rising wellness priorities, and innovative tech integration to drive market
12.3 EUROPE
12.3.1 GERMANY
12.3.1.1 Strong commitment to AI and digital health to expand market
12.3.2 FRANCE
12.3.2.1 Increasing launch of new nutraceuticals and functional foods to drive market
12.3.3 UK
12.3.3.1 Presence of key industry players and rising focus on personalized dietary solutions to drive market
12.3.4 ITALY
12.3.4.1 Increased investment in personalized health solutions to fuel market growth
12.3.5 SPAIN
12.3.5.1 Rising health awareness and technological advancements to drive market
12.3.6 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 CHINA
12.4.1.1 Growing focus on personalized nutritional strategies and national health policy goals to drive market
12.4.2 INDIA
12.4.2.1 Surge in cardiovascular disease deaths to drive market
12.4.3 JAPAN
12.4.3.1 Rising aging population and increased health risks to drive market
12.4.4 SINGAPORE
12.4.4.1 National Precision Medicine Programme to drive market
12.4.5 AUSTRALIA & NEW ZEALAND
12.4.5.1 Research innovations and increasing demand for personalized health solutions to fuel market
12.4.6 INDONESIA
12.4.6.1 Government initiatives to expand genomic technology to drive market
12.4.7 MALAYSIA
12.4.7.1 Increasing awareness of precision nutrition among youth to fuel market
12.4.8 THAILAND
12.4.8.1 Advancements in genomics ecosystem to drive market
12.4.9 VIETNAM
12.4.9.1 Collaborations in genomics technology development to drive market
12.4.10 REST OF ASIA PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.1.1 Government focus on tackling malnutrition and obesity through better nutrition to drive market
12.5.2 ARGENTINA
12.5.2.1 Focus on managing non-communicable diseases to accelerate market growth
12.5.3 REST OF SOUTH AMERICA
12.6 REST OF THE WORLD
12.6.1 AFRICA
12.6.1.1 Enhanced healthcare infrastructure and cooperation with global entities to drive market
12.6.2 MIDDLE EAST
12.6.2.1 Advancements in genomics, personalized healthcare, and digital health technologies to accelerate market growth
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2024
13.3 REVENUE ANALYSIS, 2021-2023
13.4 MARKET SHARE ANALYSIS, 2023
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Service type footprint
13.5.5.4 Technology footprint
13.5.5.5 Application footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 COMPANY VALUATION AND FINANCIAL METRICS
13.8 PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
13.9.2 DEALS
13.9.3 EXPANSIONS
13.9.4 OTHERS
13.10 KEY PLAYER STRENGTH ANALYSIS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 PRENETICS GLOBAL LIMITED
14.1.1.1 Business overview
14.1.1.2 Products/Solutions/Services offered
14.1.1.3 MnM view
14.1.1.3.1 Key strengths
14.1.1.3.2 Strategic choices
14.1.1.3.3 Weaknesses and competitive threats
14.1.2 VIOME LIFE SCIENCES, INC.
14.1.2.1 Business overview
14.1.2.2 Products/Solutions/Services offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches
14.1.2.3.2 Deals
14.1.2.3.3 Others
14.1.2.4 MnM view
14.1.2.4.1 Key strengths
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses and competitive threats
14.1.3 ZOE LIMITED
14.1.3.1 Business overview
14.1.3.2 Products/Solutions/Services offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches
14.1.3.4 MnM view
14.1.3.4.1 Key strengths
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 DAYTWO INC.
14.1.4.1 Business overview
14.1.4.2 Products/Solutions/Services offered
14.1.4.3 Recent developments
14.1.4.3.1 Others
14.1.4.4 MnM view
14.1.4.4.1 Key strengths
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses and competitive threats
14.1.5 23ANDME, INC.
14.1.5.1 Business overview
14.1.5.2 Products/Solutions/Services offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches
14.1.5.3.2 Deals
14.1.5.4 MnM view
14.1.5.4.1 Key strengths
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 THORNE
14.1.6.1 Business overview
14.1.6.2 Product/Solutions/Services offered
14.1.6.3 MnM view
14.1.7 GENESIS HEALTHCARE CO.
14.1.7.1 Business overview
14.1.7.2 Products/Solutions/Services offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches
14.1.7.3.2 Deals
14.1.7.4 MnM view
14.1.8 AJINOMOTO CO., INC.
14.1.8.1 Business overview
14.1.8.2 Products/Solutions/Services offered
14.1.8.3 MnM view
14.1.9 AMILI
14.1.9.1 Business overview
14.1.9.2 Products/Solutions/Services offered
14.1.9.3 Recent developments
14.1.9.3.1 Others
14.1.9.4 MnM view
14.1.10 DNALYSIS
14.1.10.1 Business overview
14.1.10.2 Products/Solutions/Services offered
14.1.10.3 MnM view
14.1.11 MYDNA LIFE AUSTRALIA PTY LTD.
14.1.11.1 Business overview
14.1.11.2 Products/Solutions/Services offered
14.1.11.3 Recent developments
14.1.11.3.1 Deals
14.1.11.4 MnM view
14.1.12 NUTRIGENOMIX
14.1.12.1 Business overview
14.1.12.2 Products/Solutions/Services offered
14.1.12.3 MnM view
14.1.13 SELFDECODE
14.1.13.1 Business overview
14.1.13.2 Products/Solutions/Services offered
14.1.13.3 Recent developments
14.1.13.3.1 Deals
14.1.13.4 MnM view
14.1.14 XCODE LIFE
14.1.14.1 Business overview
14.1.14.2 Products/Solutions/Services offered
14.1.14.3 Recent developments
14.1.14.3.1 Product launches
14.1.14.4 MnM view
14.1.15 GENEQUEST INC.
14.1.15.1 Business overview
14.1.15.2 Products/Solutions/Services offered
14.1.15.3 Recent developments
14.1.15.3.1 Product launches
14.1.15.3.2 Deals
14.1.15.4 MnM view
14.2 OTHER PLAYERS
14.2.1 METAGEN, INC.
14.2.1.1 Business overview
14.2.1.2 Products/Solutions/Services offered
14.2.1.3 MnM view
14.2.2 HOLIFYA S.R.L.
14.2.2.1 Business overview
14.2.2.2 Products/Solutions/Services offered
14.2.2.3 Recent developments
14.2.2.3.1 Others
14.2.2.4 MnM view
14.2.3 LIFENOME INC.
14.2.3.1 Business overview
14.2.3.2 Products/Solutions/Services offered
14.2.3.3 Recent developments
14.2.3.3.1 Product launches
14.2.3.4 MnM view
14.2.4 GENOPALATE INC.
14.2.4.1 Business overview
14.2.4.2 Product/Solutions/Services offered
14.2.4.3 Recent developments
14.2.4.3.1 Product launches
14.2.4.3.2 Others
14.2.4.4 MnM view
14.2.5 SUN GENOMICS
14.2.5.1 Business overview
14.2.5.2 Products/Solutions/Services offered
14.2.5.3 Recent developments
14.2.5.3.1 Product launches
14.2.5.3.2 Deals
14.2.5.3.3 Expansions
14.2.5.4 MnM view
14.2.6 GX SCIENCES, LLC
14.2.6.1 Business overview
14.2.6.2 Products/Solutions/Services offered
14.2.6.3 MnM view
14.2.7 SEGTERRA, INC.
14.2.7.1 Business overview
14.2.7.2 Products/Solutions/Services offered
14.2.7.3 Recent developments
14.2.7.3.1 Product launches
14.2.7.3.2 Others
14.2.7.4 MnM view
14.2.8 NUTRISENSE
14.2.8.1 Business overview
14.2.8.2 Products/Solutions/Services offered
14.2.8.3 MnM view
14.2.9 CENTURY GENOMICS LIMITED
14.2.9.1 Business overview
14.2.9.2 Products/Solutions/Services offered
14.2.9.3 MnM view
14.2.10 GENEUSDNA
14.2.10.1 Business overview
14.2.10.2 Products/Solutions/Services offered
14.2.10.3 MnM view
15 ADJACENT AND RELATED MARKETS
15.1 INTRODUCTION
15.2 LIMITATIONS
15.3 PERSONALIZED NUTRITION MARKET
15.3.1 MARKET DEFINITION
15.3.2 MARKET OVERVIEW
15.4 NUTRITIONAL ANALYSIS MARKET
15.4.1 MARKET DEFINITION
15.4.2 MARKET OVERVIEW
15.5 DIETARY SUPPLEMENTS MARKET
15.5.1 MARKET DEFINITION
15.5.2 MARKET OVERVIEW
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
